Feasibility of WB-EMS in Frail Older People
Feasibility and Safety of Whole-Body Electromyostimulation (WB-EMS) in Frail Older People: A Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
Exercise in general and resistance training (RT) in particular have demonstrated positive effects on physical functioning and frailty. However, frail older people with functional impairments are among the least physically active and may have problems reaching high intensity levels. The use of special vests with integrated electrodes allows the simultaneous innervation of all large muscle groups by external electrical stimulation, inducing a high-intensity RT at low subjective effort level. This whole-body electromyostimulation (WB-EMS) may be a feasible option inducing training stimuli for functionally impaired frail older people. This study aims at investigating the feasibility and safety of WB-EMS in frail older people with functional limitations. To explore the effects of age and functional status, young and robust old reference groups will serve as comparators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2020
CompletedStudy Start
First participant enrolled
July 22, 2020
CompletedFirst Posted
Study publicly available on registry
August 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2021
CompletedApril 28, 2021
April 1, 2021
5 months
July 10, 2020
April 27, 2021
Conditions
Outcome Measures
Primary Outcomes (9)
Recruitment rate
measured by ratio of included/eligible participants
8 weeks
Compliance
measured by proportion of attended training sessions
from baseline to 8 weeks
Retention rate
measured by proportion of participants remaining in the study
at 8 weeks
Dropout rate
measured by the proportion of participants not completing the study
from baseline to 8 weeks
Perceived enjoyment measured by the Physical Activity Enjoyment Scale for Older Adults (PACES-8)
The PACES-8 comprises of 8 items on a 7-point bipolar rating scale. A sum score is calculated with higher PACES scores reflecting greater levels of enjoyment.
Change from baseline to 8 weeks
Intervention engagement measured by the Hopkins Rehabilitation Engagement Scale (HRERS)
The HRERS, reported by instructors, comprises of 5 items on a verbal rating scale from 'Never' to 'Always'. Higher scores reflect greater levels of engagement.
at 8 weeks
Concentration of Myoglobin (MB)
Concentration of MB measured in µg/l 3 hours after training
measured at baseline to week 1, week 3 and week 8
Concentration of Creatinkinase (CK)
Concentration of CK measured in U/l before, 48, 72 hours after training
measured at baseline to week 1, week 3 and week 8
estimated glomerular filtration rate (eGFR)
eGFR (creatinine clearance) measured in mL/min/1.73m² before, 48, 72 hours after training
measured at baseline to week 1, week 3 and week 8
Secondary Outcomes (17)
Rhabdomyolysis surveillance measured by a self-developed questionnaire
measured weekly
Pain assessed by the Brief Pain Inventory (BPI-SF)
measured at baseline to week 1, week 3 and week 8
Fatigue assessed by the Brief Fatigue Inventory (BFI)
measured at baseline to week 1, week 3 and week 8
System usability measured by the System Usability Scale (SUS)
once at 8 weeks
Lower extremity functioning measured by the Short Physical Performance Battery (SPPB)
Change from baseline to 9 weeks
- +12 more secondary outcomes
Other Outcomes (11)
Health-related quality of life measured by the patient-reported Health Survey Short Form (SF-12)
Change from baseline to 9 weeks
Concentration of Interleukin 6 (IL-6)
measured at baseline to week 1, week 3 and week 8
Concentration of High-sensitivity C-reactive protein (hs CRP)
measured at baseline to week 1, week 3 and week 8
- +8 more other outcomes
Study Arms (3)
WB-EMS_frail
EXPERIMENTALWB-EMS_robust
ACTIVE COMPARATORWB-EMS_young
ACTIVE COMPARATORInterventions
Whole-Body Electromyostimulation (WB-EMS): Simultaneous, individually adjustable stimulation of 12 muscle groups using an interval approach with a duty cycle of 6s impulse/4s rest, bipolar electric current (impulse -frequency 85Hz, -width 350μs, rectangular pattern) will be applied. After a 4-week conditioning period, 1.5x 20 min/week WB-EMS will be conducted for 4 weeks (total training duration 8 weeks). Easy to perform functional exercises focusing on balance, transfer ability, stepping and lower extremity strength/power will be done during WB-EMS. Exercise intensity will be individually prescribed and adjusted by rate of perceived exertion (RPE-Borg CR10 scale 4 (moderate) to 7 (hard)). WB-EMS will be fully supervised one on one. All three arms will receive the same intervention.
Eligibility Criteria
You may qualify if:
- + years
- Frail
- able to walk 4m w/o walking aid
- no prior WB-EMS exposure
You may not qualify if:
- severe visual or hearing impairments
- major cognitive impairment (MMSE \<10)
- medications with muscle-anabolic effects
- medical conditions affecting trainability of muscles (e.g. Myasthenia gravis, Cushing syndrome, Morbus McArdle)
- surgery within past two months
- history of rhabdomyolysis
- medical conditions affecting sensation of electrical stimuli (e.g. severe polyneuropathy)
- severe renal insufficiency (eGFR\<30 ml/min/1.73m²)
- electronic implants
- acute or untreated abdominal wall or inguinal hernia
- Robust people
- + years
- Robust
- no prior WB-EMS exposure
- severe visual or hearing impairments
- +24 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Medical Physics, University of Erlangen-Nürnberg
Erlangen, 91052, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2020
First Posted
August 3, 2020
Study Start
July 22, 2020
Primary Completion
December 31, 2020
Study Completion
February 28, 2021
Last Updated
April 28, 2021
Record last verified: 2021-04